NVAX Competitors & Alternatives
Compare Novavax Inc with similar stocks in the same industry
Biotechnology
NVAX
Main Stock$9.74
Tradestie Score
54
Market Cap
$1.54B
Revenue Growth
-0.8%
Analyst Upside
+44.9%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MPLT
MPLT
|
$37.09
|
$1.63B | - | 53 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.56
|
$1.63B | - | 58 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.96
|
$1.57B | - | 57 | Compare |
|
VCEL
Vericel Corporation
|
$46.98
|
$1.56B | 105.0 | 59 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$94.34
|
$1.55B | - | 57 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$37.26
|
$1.55B | 14.5 | 65 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$33.86
|
$1.55B | - | 61 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.61
|
$1.50B | 7.3 | 55 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$53.45
|
$1.50B | - | 57 | Compare |
|
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
|
$18.27
|
$1.49B | - | 59 | Compare |
More NVAX Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2836)
234 stocks in this industry